OPEN MIC Next in Health - Generative AI in healthcare: Hype or hope?

Date

04.12.2023, 16:30 – 17:45 CET on site* and online

Location

Novartis Pavillon in Basel

Register

OPEN MIC Next in Health Series invites leaders from vastly different backgrounds to take the mic in a relaxing yet controversial conversation and share their views on the future of health. This edition focuses on Generative AI and its influence in lifesciences.

Generative AI (Gen-AI) relies on deep-learning algorithms to create content and comprehensive insights. Its breakthrough lies in its capacity to understand natural language and to take input from vast data sets, analyze them in record time and provide as output text, audio, code and more.

ChatGPT has propelled Gen-AI and large language models into the mainstream across multiple industries, including healthcare and life sciences. In these areas where safety and reliability come first, proper validation is expected before adopting this new tool. Use cases that were unthinkable a couple of years ago are now possible, which begs the promise of long-term benefits in this high-risk industry. Can we leverage this impressive technology in health innovation to reduce costs and improve healthcare performance and patient outcomes? And how does Gen-AI benefit tech companies and start-ups?

Speakers on stage:

Blaise Jacholkowski, Senior Business Solution Manager Digital Health at Zühlke
Jas Dhalliwal, Global Principal Cloud Architect at Google
Jan Beger, Senior Director Digital Ecosystem at GE Healthcare
Lisa Falco, Lead Data & AI Consultant, Femtech Expert at Zühlke

Swiss Venture Capital Report TEST

The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". You can download it in our assets section.